Menu

Inspiring Innovation, Leica Biosystems Introduces the Next-Gen BOND RX IHC, ISH and Emerging Tests Stainer

Jun 28, 2018
Leica Biosystems

Simplify your research in cancer biology and discover new approaches to diagnosis with the new BOND RX next generation research stainer by Leica Biosystems. The BOND RX system provides researchers with the ability to design their ideal protocol. With customization options across all protocol editing segments, the BOND RX enables greater flexibility when optimizing conditions for a variety of test types including IF, ISH, FISH, TUNEL, TSA, CTC, Multiplexing and other emerging tests. Geared toward expanding the user’s freedom to discover, the latest advances to the BOND RX include enhancements to improve the overall user experience. Coupled with an expansion to the system’s customization capabilities, researcher’s now have more options to explore their ideas. Primary Features of the new BOND RX include:

 • Protocol Customization Advancements
     o Customize your dewax options. Add or subtract as many dewax steps as needed.
     o Choose from six unique probe application and removal protocols. Select the protocol that best suits your probe.
     o Select your dispense type with a choice of 3 different reagent flow options.
• Reagent Visual Management Lighting System
     o Reagents are illuminated and provide clear visual alerts to users at a glance.
• New software version 6.0
     o New highly visual user interface with easy to identify iconography. 

“With science advancing at such a rapid rate, it is an exciting time to be supporting researchers as they seek to unlock the complexity of cancer biology and develop new approaches to diagnosis” said Colin White, PhD Global Vice President – Advanced Staining at Leica Biosystems. “The release of the next generation of BOND RX is an important milestone in providing our customers with broader experimental flexibility and improved usability”. Leica Biosystems has an open system across the workflow and an optimized product portfolio that offers you the reproducibility and flexibility you need to uncover critical details. Spend less time on manual tasks and more time innovating to find answers – helping you obtain the data needed to secure funding for that next breakthrough discovery. The new BOND RX automated researcher stainer, featuring enhanced usability and increased protocol editing flexibility is available in USA.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.